Cell Industry Conference 2022 conference plan is released: April Shanghai, August Shenzhen, November Wuhan, looking forward to your joining!

Conferences

1.

• Stem cell pre-clinical research and transformation application

• Stem cell pre-clinical research and clinical application transformation

• Stem cell therapy technology and clinical research

• Quality evaluation of preparations for clinical research on stem cells and immune cells

• Current status and future of stem cell therapy quality control management

• Stem cell and organoid research

• Application of stem cell exosomes

• Stem cells and regenerative medicine

• Treatment of refractory diseases with extra-vesicles of mesenchymal stem cells

• New type of stem cells to treat new coronary pneumonia

2.

• Breakthrough in research and development and commercialization of cellular immunotherapy

• Universal CAR-T cell immunotherapy

• Cellular immunotherapy quality control & industrialization

• Cell therapy drug development and commercial production

• Cell therapy product development and process optimization

• Technical challenges and development trends of TIL cells in the treatment of solid tumors

• CAR innate immune cells derived from iPSC and its application in tumor immune cell therapy

• Multi-omics study of extracellular vesicles

• Analysis and application of RNA components of extracellular vesicles

• Development and clinical transformation of exosome technology

3.

• Single cell multi-omics research and clinical application

• Single-cell transcriptome technology is dedicated to the study of brain development and neural stem cell regulation

• Scientific innovation frontiers and latest technologies in single-cell multi-omics

• Development and application progress of single-cell spaceomics

• Single cell technology helps precision medicine research

• Application of single-cell omics research technology in tumor immunity and personalized therapy

• Application of single-cell technology in the investigation of tumor microenvironment and tumor cell heterogeneity

• Single-cell sequencing combined with the application of multi-omics technology

4.

• Clinical research and industrial transformation of cell and gene therapy

• The latest research progress of cell and gene therapy at home and abroad

• Cell and Gene Therapy CDMO

• Gene therapy and development of oncolytic virus products

• Research on the large-scale production process and cost control of AAV gene therapy drugs

• Large-scale production of gene therapy GMP virus vector

• Research on genetically engineered exosomes for tumor targeted therapy

• Oncolytic virus and RNA therapy

5.
3D cell culture and organoid clinical application summit

• 3D cell culture and frontier progress of organoids

• Development and Application of 3D Organoid Culture Technology

• Organoid basic research and technology development

• Organoid clinical medicine research and application

• Organoid drug screening and biomanufacturing

• Scientific research application and clinical transformation of organoid technology

• Application of organoids in tumor precision medicine research

• Application and progress of organoids in companion diagnosis and new drug development

• Application of microfluidic organ chips in precision medicine and drug development

* The final agenda is subject to the scene, and the speaking companies can make their own topics

Guests to be invited (in no particular order)

Chen Guoqiang, Academician of Chinese Academy of Sciences

Meng Shufang, Researcher, Cell Room, China Food and Drug Control Research Institute for Biological Products

Wu Zhaohui, Vice Chairman of China Medical Biotechnology Association

Han Weidong, Director of the Department of Biotherapy, Chinese People's Liberation Army General Hospital

Mao Hongju, Shanghai Institute of Microbial Systems and Information Technology, Chinese Academy of Sciences

Liu Xingguo, Researcher, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences

Wang Ran, Associate Researcher, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences

Tang Fuchou, Professor of BIOPIC Center, School of Life Sciences, Peking University, Deputy Director of Beijing Future Genetic Diagnosis High-precision Innovation Center

Wang Yaohe, Director of China National Cell and Gene Therapy International Joint Research Center

Su Bing, Professor of Shanghai Institute of Immunology, School of Medicine, Shanghai Jiaotong University

Liu Baochi, Professor of Shanghai Public Health Clinical Center

Liu Zhongmin, Dean of Dongfang Hospital Affiliated to Tongji University

Lin Xinhua, Executive Dean, School of Life Sciences, Fudan University, Director of the Institute of Genetics, Director of the State Key Laboratory of Genetic Engineering

Yin Zhinan, Dean of the Institute of Translational Medicine, Jinan University

Liu Yan, Deputy Director and Distinguished Professor of the Institute of Stem Cell and Neural Regeneration, School of Pharmacy, Nanjing Medical University

Chen Zaozao, Suzhou Institute of Medical Devices, Southeast University

Sun Wei, National Distinguished Professor, Department of Mechanical Engineering, Tsinghua University

He Kangxin, the First Affiliated Hospital of Zhejiang University School of Medicine

Yang Chaoyong, Deputy Dean of the Institute of Molecular Medicine, Shanghai Jiaotong University

Xin Zou, PhD in Statistical Signal Processing, University of Birmingham, UK, Head of Bioinformatics Platform and Associate Researcher of Jinshan Hospital Affiliated to Fudan University

Wu Weizhong, Director of the Laboratory of Liver Cancer Research Institute, Zhongshan Hospital, Fudan University

Pei Duanqing, Professor of West Lake University

Shi Yufang, Professor of Soochow University

Li Bin, researcher at Shanghai Institute of Immunology

More guests are invited, and all units are welcome to recommend themselves!

*Finally subject to the scene

Who will participate

• Chief physicians, deputy chief physicians, attending physicians, and related fields of the deans, hospital administrators, medical oncology, oncology surgery, biotherapy, hematology, pathology, assisted reproduction, laboratory and other departments of major hospitals across the country Research experts, scientific researchers, pharmaceutical companies, etc.

  
  ;
  

• Scientific research institutes, biomedical companies, technical service agents and investment institutions, clinicians, etc.

  
  ;
  

• Professors, researchers, associate researchers and majors in life sciences, pharmacy, medicine, immunology, etc.

  
  from well-known universities;
  

• Cell and tumor antibody immunotherapy upstream suppliers, diagnostic reagents and equipment service providers, technology and equipment equipment providers, IT big data solution providers, etc.
  ;

• Technicians and R&D directors such as gene therapy, gene editing, gene sequencing, gene testing companies, biotechnology company R&D personnel, etc.
  ;

• Precision medical institutions, enterprises, cell storage and treatment enterprises, CROs, CMOs, etc.
  ;

• CEO and head of pharmaceutical company R&D: antibody immunotherapy drug development, immune cell therapy and product development, oncolytic viruses, therapeutic vaccines, small molecule immunotherapy drugs, cell therapy and regenerative medicine experts, clinical researchers, practitioners , Graduate students, medical supplies researchers and manufacturers in the field of cell therapy and regenerative medicine, etc.
  ;

• And representatives of government agencies, industrial parks, Merchants, investment incubators, consulting and training institutions, banks, lawyers, intellectual property, securities companies
  .
  

2021 event review

The 2021 Cell Industry Conference 2021 6th (Shanghai) Cell and Tumor Precision Medicine Summit Forum, accompanied by a two-day conference and a three-day exhibition, will be held at the Shanghai Exhibition Center (1000 Yan'an Middle Road, Jing'an District, Shanghai) on April 25th.

Gallery of Shanghai Conference on April 23-25, 2021

2021 Cell Industry Conference 2021 Seventh (Shenzhen) Cell and Tumor Precision Medicine Summit Forum/2021 Gene and Precision Diagnosis and Treatment (Shenzhen) Summit Forum/2021 Tumor Precision Diagnosis and Treatment (Shenzhen) Forum accompanied by a two-day conference and exhibition in October The curtain came to an end at the Shenzhen Convention and Exhibition Center on the 27th! During the special period of the epidemic, this conference adopted a combination of “online (about 120,000 people watching) + offline (more than 600 participants)”.

Photo Gallery of Shenzhen Conference on October 26-27, 2021

Upcoming Events

2022 Cell Industry Conference

2022 The 9th (Shenzhen) Cell and Tumor Precision Medicine Summit Forum

Time: August 2022

Location: Shenzhen

2022 Cell Industry Conference

2022 10th (Wuhan) Cell and Tumor Precision Medicine Summit Forum

Time: November 2022

Location: Wuhan

Sponsors/cooperative media are recruiting, welcome to write to 695114062@qq.
com for communication
.

Conference consultation: Li Yang 17717078907 (same number on WeChat)